These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22146741)

  • 1. Central venous catheter repair is associated with an increased risk of bacteremia and central line-associated bloodstream infection in pediatric patients.
    Lundgren IS; Zhou C; Malone FR; McAfee NG; Gantt S; Zerr DM
    Pediatr Infect Dis J; 2012 Apr; 31(4):337-40. PubMed ID: 22146741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Rates of Central Line-Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters.
    Dube WC; Jacob JT; Zheng Z; Huang Y; Robichaux C; Steinberg JP; Fridkin SK
    JAMA Netw Open; 2020 Mar; 3(3):e200396. PubMed ID: 32129868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
    Concannon C; van Wijngaarden E; Stevens V; Dumyati G
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying odds of bloodstream infection in repaired silastic central venous catheters in a pediatric population.
    Taroc AM; Sullivan E
    Br J Nurs; 2023 Apr; 32(7):S32-S36. PubMed ID: 37027414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of enterococcal central line-associated bloodstream infections in patients with cancer.
    Awadh H; Chaftari AM; Khalil M; Fares J; Jiang Y; Deeba R; Ali S; Hachem R; Raad II
    BMC Infect Dis; 2021 Jul; 21(1):643. PubMed ID: 34225651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the multimodal intervention including an automatic notification of catheter days on reducing central line-related bloodstream infection: a retrospective, observational, quasi-experimental study.
    Bae S; Kim Y; Chang HH; Kim S; Kim HJ; Jeon H; Cho J; Lee J; Chae H; Han G; Kim SW
    BMC Infect Dis; 2022 Jul; 22(1):604. PubMed ID: 35804323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central Venous Catheter Salvage in Ambulatory Central Line-Associated Bloodstream Infections.
    Ford WJH; Bundy DG; Oyeku S; Heo M; Saiman L; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Klein E; Obaro-Best O; Drasher M; Peshansky A; Rinke ML
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractured pediatric central venous catheters - Repair or replace?
    Zens T; Nichol P; Leys C; Haines K; Brinkman A
    J Pediatr Surg; 2019 Jan; 54(1):165-169. PubMed ID: 30466713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
    Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central venous catheter repair is highly successful in children with intestinal failure.
    Chan AP; Baldivia PS; Reyen LE; Lund AN; Marcus EA; Venick RS; Vargas JH; Wozniak LJ
    J Pediatr Surg; 2019 Mar; 54(3):517-520. PubMed ID: 29980344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
    Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.
    Chaftari AM; El Zakhem A; Jamal MA; Jiang Y; Hachem R; Raad I
    BMC Infect Dis; 2014 Sep; 14():518. PubMed ID: 25253042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
    Weber JM; Sheridan RL; Fagan S; Ryan CM; Pasternack MS; Tompkins RG
    J Burn Care Res; 2012; 33(4):539-43. PubMed ID: 22210071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central-Line-Associated Bloodstream Infections (CLABSIs) Incidence and the Role of Obesity: A Prospective, Observational Study in Greece.
    Tsolakoglou I; Intas G; Stergiannis P; Sakkou A; Chalari E; Tsoumakas K; Elefsiniotis I; Fildissis G
    Adv Exp Med Biol; 2020; 1196():11-18. PubMed ID: 32468303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.
    Baier C; Linke L; Eder M; Schwab F; Chaberny IF; Vonberg RP; Ebadi E
    PLoS One; 2020; 15(1):e0227772. PubMed ID: 31978169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
    Chong CY; Ong RY; Seah VX; Tan NW; Chan MY; Soh SY; Ong C; Lim AS; Thoon KC
    J Paediatr Child Health; 2020 Jan; 56(1):123-129. PubMed ID: 31145505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience.
    Chang AK; Foca MD; Jin Z; Vasudev R; Laird M; Schwartz S; Qureshi M; Kolb M; Levinson A; Bhatia M; Kung A; Garvin J; George D; Della-Latta P; Whittier S; Saiman L; Satwani P
    Am J Infect Control; 2016 Dec; 44(12):1650-1655. PubMed ID: 27378008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.